Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

NCT03039790 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
528
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda